TRxADE Health renamed Scienture Holdings; ticker changes to SCNX on Nasdaq

Scienture Holdings, Inc.

Name change effective September 23, 2024; new CUSIP 80880X104.
Stock now trades on Nasdaq under ticker SCNX; old ticker MEDS discontinued.
Prior all-stock business combination with Scienture LLC valued at $103 million.
Executive team and board unchanged; Suren Ajjarapu remains CEO and Chairman.
Subsidiaries include Scienture LLC (specialty pharma) and Integra Pharma Solutions (wholesale).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.